Today: 27 June 2026
Micron Stock Price Falls 4% as Google’s TurboQuant, SK Hynix Expansion Rattle AI Memory Trade
26 March 2026
1 min read

Micron Stock Price Falls 4% as Google’s TurboQuant, SK Hynix Expansion Rattle AI Memory Trade

NEW YORK, March 26, 2026, 10:05 EDT

Micron Technology fell roughly 4.2% to $366.23 early Thursday in New York, trading below its previous close of $382.09 from Wednesday.

This shift packs a punch. Micron holds a crucial spot in the AI memory supply chain, right up there with Samsung Electronics and SK Hynix—the trio controlling most of the world’s memory output. All three have been benefiting from the tight supply caused by AI data-center buildouts. High-bandwidth memory (HBM), stacked right alongside those AI processors, is the hot commodity.

Every notch lower in memory appetite counts. This week, Google Research claimed TurboQuant slashes “key-value cache” memory—used by large language models to remember prior tokens—by a factor of six or more, all without dinging accuracy. On H100 hardware, some computations reportedly jump as much as eightfold. Google Research

Micron’s timing isn’t ideal here, landing just a week after it posted a blowout quarter. The company projected third-quarter revenue at $33.5 billion—well ahead of what Wall Street was expecting. Still, shares dropped after Micron revealed it plans to lift 2026 capital spending by $5 billion, bringing the total to over $25 billion. The bigger budget “makes sense, given the shape of the demand,” Ben Bajarin at Creative Strategies told Reuters. Reuters

Micron’s tone remains upbeat. CEO Sanjay Mehrotra, writing on the company’s investor page, pointed to record highs in revenue, gross margin, EPS, and free cash flow. He described memory as “a strategic asset” for AI-focused customers. Micron Technology

Supply remains tight, at least for now. In comments prepared last week, Micron described NAND demand as “significantly in excess” of available supply. The company also projected that supply-demand dynamics for DRAM—the core memory in phones and servers—and for NAND, which handles data storage, are likely to remain constrained past 2026.

Competitors are betting big that the crunch isn’t going away. SK Hynix, for one, revealed plans this week for a confidential U.S. listing, eyeing up to $14 billion. Just the day before, it announced a nearly $8 billion order with ASML for extreme ultraviolet equipment—the gear behind the sharpest chip designs—to ramp up its advanced memory production.

Micron is moving forward, too. According to Reuters on March 16, the company’s prepping a second plant at the Tongluo location in Taiwan. Meanwhile, Micron also announced the launch of high-volume HBM4 production, targeting Nvidia’s Vera Rubin platform.

The bear scenario doesn’t ask much. Should tools like TurboQuant catch on more quickly and chipmakers push capacity too far, the pricing tailwind that’s bolstered memory shares could lose steam earlier than many expect. Lately, analysts have zeroed in on that combination—less demand per device, looming surplus.

Plenty of Wall Street voices aren’t on board with the bearish view. Morgan Stanley’s Joseph Moore called the drop “a healthy pricing in of durability concerns,” but pushed back, saying memory still sets the pace for AI demand, not the opposite. tipranks.com

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 24.03.2026

XRP Price Today Drops to $1.36 as Oil Spike and Iran War Jitters Hit Crypto
Next Story

XRP Price Today Drops to $1.36 as Oil Spike and Iran War Jitters Hit Crypto

Go toTop